| Autor: |
Radjenovic S; Functional Brain Diagnostics and Therapy, Department of Neurology, Medical University of Vienna, Spitalgasse 23, A-1090 Vienna, Austria., Dörl G; Functional Brain Diagnostics and Therapy, Department of Neurology, Medical University of Vienna, Spitalgasse 23, A-1090 Vienna, Austria., Gaal M; Functional Brain Diagnostics and Therapy, Department of Neurology, Medical University of Vienna, Spitalgasse 23, A-1090 Vienna, Austria., Beisteiner R; Functional Brain Diagnostics and Therapy, Department of Neurology, Medical University of Vienna, Spitalgasse 23, A-1090 Vienna, Austria. |
| Abstrakt: |
Transcranial ultrasound holds much potential as a safe, non-invasive modality for navigated neuromodulation, with low-intensity focused ultrasound (FUS) and transcranial pulse stimulation (TPS) representing the two main modalities. While neuroscientific and preclinical applications have received much interest, clinical applications are still relatively scarce. For safety considerations, the current literature is largely based on guidelines for ultrasound imaging that uses various physical parameters to describe the ultrasound pulse form and expected bioeffects. However, the safety situation for neuromodulation is inherently different. This article provides an overview of relevant ultrasound parameters with a focus on bioeffects relevant for safe clinical applications. Further, a retrospective analysis of safety data for clinical TPS applications in patients is presented. |
